U.S. market Closed. Opens in 11 hours 26 minutes

DCPH | Deciphera Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue163.36M134.04M96.15M42.09M25.00MN/AN/AN/AN/A
Cost of Revenue3.73M8.77M2.93M225.00K830.00KN/AN/AN/AN/A
Gross Profit159.62M125.27M93.22M41.86M24.17MN/AN/AN/AN/A
Operating Expenses370.58M307.99M393.29M313.05M225.73M104.10M50.94MN/AN/A
Selling, General & Admin136.46M120.17M136.25M114.08M68.12M21.21M11.42M5.67M5.13M
Research & Development234.12M187.82M257.04M198.97M157.61M82.89M39.51M20.16M12.47M
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-210.96M-182.72M-300.08M-271.19M-200.73M-104.10M-50.94M-25.84M-17.61M
Other Expenses / Income16.45M4.51M113.00K4.70M8.47M4.25M651.00K-102.00K-2.21M
Before Tax Income-194.51M-178.21M-299.96M-266.49M-192.26M-99.85M-50.28M-25.94M-19.82M
Income Tax Expenses431.00K722.00K-3.13MN/A-763.00K4.33MN/AN/AN/A
Net Income-194.94M-178.93M-296.84M-266.49M-191.49M-99.85M-50.28M-25.94M-19.82M
Interest ExpensesN/A4.51MN/AN/A67.00K84.00K95.00K106.00K2.21M
Basic Shares Outstanding85.06M75.50M58.08M55.78M42.87M35.39M16.79M17.92M20.90M
Diluted Shares Outstanding85.06M75.50M58.08M55.78M42.87M35.39M16.79M17.92M20.90M
EBITDA-208.86M-182.72M-300.08M-264.18M-192.19M-99.77M-50.04M-25.74M-17.53M
EBITDA Margin-127.85%-136.32%-312.10%-627.71%-768.76%0.00%0.00%0.00%0.00%
EBIT-194.51M-173.70M-299.96M-266.49M-192.19M-95.44M-50.19M-25.83M-17.61M
EBIT Margin-119.07%-129.59%-311.98%-633.19%-768.76%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙